Brain stimulation with a medicine for cervical dystonia, guided by brain scans
Tests magnetic brain stimulation plus trihexyphenidyl in adults with cervical dystonia.
Key facts
- Who runs it
- Duke University
- Where
- Durham, United StatesSee the site
- Trial code
- Registry title
- Accelerating TMS for Cervical Dystonia
- Status
- Enrolling by invitation
- Phase
- Phase 2
- People taking part
- 50 people, planned
- Started
- 17 Dec 2024
- Expected to end
- 1 Jul 2029
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Transcranial Magnetic Stimulation (TMS)
- Placebo
- trihexyphenidyl 10mg
- Record updated
- 5 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with cervical dystonia, a condition that causes involuntary neck muscle movements. Some people taking part are considering deep brain stimulation (DBS) surgery.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Isolated cervical dystonia diagnosed by a neurologist. For the DBS group: cervical dystonia diagnosed by a neurologist.
- Earlier treatment
- No botulinum toxin injections within 3 months. Main group: no dystonia medicines (such as anticholinergic, benzodiazepines, muscle relaxants), no TMS for another reason, and no neck physical or occupational therapy within one month. DBS group: no medicine or one medicine for dystonia for at least one month before the study.
Main reasons for not taking part
- Other movement disorders, such as Parkinsonism, essential tremor or, for the main group, other types of dystonia
- History of seizures, or medicines that lower the seizure threshold or treat seizures
- Illicit drug use
- Any reason you cannot have MRI or TMS
- Cannot read or cannot sign informed consent
The registry criteria, word for word
Show all 23 criteriaShow less
Who can take part
- 18yrs and older
- Diagnosed with isolated cervical dystonia by Neurologist
- Must be able to sign an informed consent
- Must be literate
- 18yrs and older
- diagnosed with cervical dystonia by a Neurologist
- must be able to sign informed consent
- must be literate
- On no medications or one medication to treat symptoms of dystonia for a minimum of one month prior to study participation
Who cannot take part
- Concomitant medications known to decrease seizure threshold
- Illicit drug use
- No TMS therapy for another indication within one month of this research study
- Medications used for symptom treatment of dystonia including anticholinergic, benzodiazepines, and muscle relaxants among others within one month of the study
- No physical or occupational therapy of the neck within one month of the study
- More than two medications used for symptom treatment of dystonia including anticholinergic, benzodiazepines, and muscle relaxants among others within one month of the study
- Other neurological movement disorders diagnoses including other types of dystonia, Parkinsonism, or essential tremor
- History of seizure disorder
- other neurological movement disorders diagnoses including Parkinsonism, or essential tremor
- a history of seizures and anti-seizure medications by review of medical records
- Botulinum toxin injections within 3 months of the research study
- Any contraindications to MRI or TMS
- botulinum toxin injections within 3 months of research study
- contraindications to MRI or TMS
Where in United States
- Duke University Health SystemDurham, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
This study aims to investigate the impact of accelerated transcranial magnetic stimulation (TMS) on brain function and behavior in patients with focal cervical dystonia. Previous research demonstrated that individualized TMS improved writing behavior in focal hand dystonia after one session. In this study, we aim to expand the application on TMS on focal cervical dystonia. The current study administers six sessions of TMS separated by five rest blocks, all in a single day and combined with a medication called trihexyphenidyl given 30 minutes before the TMS session. This approach is called "anticholinergic enhanced accelerated TMS The research involves 8 in-person visits and 3 remote visits over 28 weeks. The effect of TMS will be assessed using functional MRI brain scans and behavioral measurements. Participants who are interested in enrolling in the TMS study to assess their potential presurgical response to DBS will only receive the active TMS session combined with trihexyphenidyl medication. After active TMS + trihexyphenidyl medication, participants will be followed for 3-5months to assess their brain and behavior response to TMS. Following clinical care DBS, participants will be followed for three additional research visits. The three visits will be performed at 1 month, 3 months and 6-9 months. During the post-DBS research visits, participants will complete behavioral assay and physiological assay to evaluate their neck movements and muscles. At 3 month or 6-9 month visit, the post-DBS participants will also undergo fMRI with the DBS device in off mode setting.
Read full original descriptionShow less
The risk of TMS includes seizures; the potential risk of seizures from TMS is mitigated through careful screening, adhering to safety guidelines. The study's main benefit is enhancing dystonic behavior and deepening the understanding of brain changes caused by TMS in cervical dystonia, paving the way for further advancements in clinical therapy for this condition.
The 3 groups in the trial
- sham TMSSham treatment, for comparison
Participants receive sham TMS
Treatment: Transcranial Magnetic Stimulation (TMS) and Placebo
- TMS to primary somatosensory cortexExisting treatment, for comparison
Participants received TMS sessions at primary somatosensory cortex
Treatment: Transcranial Magnetic Stimulation (TMS) and trihexyphenidyl 10mg
- TMS to primary somatosensory cortex (Open Label DBS Participants)Existing treatment, for comparison
Participants received TMS sessions at primary somatosensory cortex
Treatment: trihexyphenidyl 10mg
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Functional Magnetic Resonance Imaging (fMRI)-Guided Individualized Transcranial Magnetic Stimulation (TMS) for Cervical Dystonia
- Plain-language title
- Brain stimulation with a medicine for cervical dystonia, guided by brain scansGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 5 November 2026